Irvine, CA. March 17, 2026 — PFD Capital Partners, Inc. (PFD) today announced that Regeneration Biomedical, Inc. (RBI) has been awarded U.S. Patent No. 12,529,034 B2, titled “WNT-Activated Adipose-Derived Stem Cell Apparatus, Methods and Systems.” The newly granted patent significantly expands RBI’s intellectual property portfolio and further positions the company at the forefront of regenerative medicine approaches for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease and other forms of dementia.